Scienture
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6308 Benjamin Rd Ste 708, Tampa, Florida...Phone Number
(800) 261-0281Website
www.scienture.comRevenue
<$5 MillionStock Symbol
SCNXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Scienture
Scienture LLC is a NY based branded, specialty pharmaceutical company. The company is a highly experienced team of industry professionals who are passionate about developing unique specialty product concepts and solutions that bring enhanced value to patients and healthcare systems. The company's assets in development are across therapeutics areas, indications and cater to different market segments.Explore more
Scienture Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Scienture your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Scienture
Product Launch: Get notified when Scienture launches new products
Click to see if Scienture had a recent Job posting/layoffs
Check if Scienture has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Scienture is spiking on competitors!
Scienture, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Scienture has new funding data
Earning: See what the market has to say on Scienture recently announced quarterly report
Recommended Actions
Find VP level buyers at Scienture
Find 2 more new buyers
Compare Similar Companies to Scienture
Compare insights from companies similar to Scienture, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Scienture is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Scienture is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Scienture.
Scienture financials insights
Gather financial insights about Scienture, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Debt
$1.2M
Scienture Tech Stack
A closer look at the technologies used by Scienture
Most Recent Scoops
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Left Company
Executive Move
Executive Moves, Left Company
Funding
Funding
Scienture News & Media
EXCLUSIVE: Scienture Expands Coverage For Opioid Overdose Treatment Ahead Of Commercial Launch
Scienture Holdings Inc. (NASDAQ:SCNX) said Tuesday that its opioid overdose treatment Rezenopy (naloxone HCl) Nasal Spray 10 mg has been added to the formulary of a large national health plan, broadening commercial and Medicare supplemental coverage ahead of the product’s planned mid-July 2026 launch. Rezenopy Coverage Extends To More Than 100 Million Lives The company said the addition increases potential access to more than 100 million covered lives across the U.S., marking another step inSCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041
U.S. Naloxone Market: ~$141 million in annual sales and 9.4 million units annuallyScienture Holdings CFO resigns; Co-CEO named interim | SCNX 8-K Filing
Scienture Holdings’ CFO Eric Sherb resigned for personal reasons, with no reported disputes. Co-CEO and President Dr. Narasimhan Mani, a veteran pharma executive with finance experience, has been appointed Interim CFO effective May 26, 2026.SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion
COMMACK, NY, May 18, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through the development, commercialization, and distribution of novel specialty products that address unmet market needs, today provided a business update and reported financial results for the three months ended March 31, 2026.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Scienture
Sign Up For FreeTo access detailed company insights
Scienture LLC is a NY based branded, specialty pharmaceutical company. The company is a highly experienced team of industry professionals who are passionate about developing unique specialty product concepts and solutions that bring enhanced value to patients and healthcare systems. The company's assets in development are across therapeutics areas,... Read More
